510(k) device
LenSx Laser System (8065000944)
Alcon Laboratories, Inc. · Ophthalmic Femtosecond Laser (OOE, Class II) · First FDA decision Nov 16, 2016, newest Sep 24, 2025Cataract
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
12
Naming "LenSx"
MAUDE reports
2,321
Brand "LenSx", since 2015
PubMed studies
122
Mentioning "LenSx"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LenSx Laser System (8065000944)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
K252682 · Decided Sep 24, 2025 · 30 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "LenSx", any status and sponsor, newest update first.
Centre hospitalier de l'Université de Montréal (CHUM)Academic, hospital or other
NCT05119270 · 0 participants · Start Dec 1, 2021 · Primary completion Mar 2026
Device: Femtosecond laser assisted cataract surgery with Active Sentry handpiece · For: Corneal Endothelial Cell Loss; Cataract; Astigmatism
Sites: Montreal, Canada
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LenSx", and for the whole product code for context.
This brand
2,321 reports: 1,036 malfunction, 1,285 injury, 0 death
Whole product code OOE
4,559 reports: 2,002 malfunction, 2,527 injury, 0 death
Newest reports for this brand
- LENSX LASER SYSTEMInjury
2028159-2026-01679 · Received Oct 29, 2026 · Event dated Oct 14, 2026
Device type: Ophthalmic Femtosecond Laser (OOE)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Capsular Bag Tear
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "LenSx"[tiab]. The summary above synthesizes these.
- Femtosecond laser cataract surgery.
Nagy ZZ, McAlinden C · Eye Vis (Lond) · 2015Review
- Femtosecond laser-assisted cataract surgery.
He L, Sheehy K, Culbertson W · Curr Opin Ophthalmol · 2011Review
- Comparing the time efficiency of two lasers used in FLACS: real-world observational study.
Heit L, Datar M, Kyriakakos M, et al. · J Cataract Refract Surg · 2024Multicenter Study, Observational Study
- [LenSx® femto-LASIK, FEMTO LDV Z4® femto-LASIK, and PRK : Comparison of refractive results and an analysis of complications].
Pahlitzsch T, Pahlitzsch ML, Sumarni U, et al. · Ophthalmologe · 2018
- Intraoperative quantitative crystalline lens nuclear opacities analysis based on crystalline lenSx platform.
Zhang Y, Zhang Y, Zhang J, et al. · BMC Ophthalmol · 2024
- THE ADVANTAGES OF FEMTOSECOND LASER-ASSISTED CATARACT SURGERY.
Gavris MM, Belicioiu R, Olteanu I, et al. · Rom J Ophthalmol · 2015Research Support, Non-U.S. Gov't
- Update and clinical utility of the LenSx femtosecond laser in cataract surgery.
Roberts TV, Lawless M, Sutton G, et al. · Clin Ophthalmol · 2016Review
- The Impact of Learning Curve on Flap Thickness Outcome in Femtosecond Laser-assisted Laser In Situ Keratomileusis Performed with New LenSx Dual Platform.
Asena BS, Donmez O · Korean J Ophthalmol · 2022
- Complications of femtosecond laser-assisted cataract surgery.
Nagy ZZ, Takacs AI, Filkorn T, et al. · J Cataract Refract Surg · 2014
- Efficacy of femtosecond laser for anterior capsulotomy in complex white cataracts.
Larco P, Larco C, Borroni D, et al. · J Fr Ophtalmol · 2023
- Anterior Capsulotomy Outcomes: A Comparison Between Two Femtosecond Laser Cataract Surgery Platforms.
Pantanelli SM, Diakonis VF, Al-Mohtaseb Z, et al. · J Refract Surg · 2015Comparative Study
- The advantages of femtosecond laser-assisted cataract surgery for zonulopathy.
Teshigawara T, Meguro A, Sanjo S, et al. · Int Med Case Rep J · 2019Case Reports
Other devices of this type
Also filed under product code OOE.
- LENSAR Laser System - fs 3D (LLS-fs 3D)Lensar, Inc. · 510(k) 2018
- VICTUS Femtosecond Laser PlatformTechnolas Perfect Vision GmbH · 510(k) 2020
- Catalys Precision Laser SystemAmo Manufacturing USA, LLC · 510(k) 2023
- Catalys Precision Laser SystemOptimedica Corporation · 510(k) 2016
- TbdLensar, Inc. · 510(k) 2013
- Lensx 550 Laser System. Model 550Lensx Lasers, Inc. · 510(k) 2010
- FEMTO LDV Z8 Femtosecond Surgical LaserSie Ag,Surgical Instrument Engineering · 510(k) 2022
- ELITA Femtosecond Laser System, ELITA Patient InterfaceJohnson & Johnson Surgical Vision, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.